Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 February 1998 | Volume 128 Issue 3 | Pages 186-193
Background: Osteoporosis occurs in patients with cystic fibrosis as they age, but its clinical implications are not well defined.
Objective: To determine the clinical effect of decreased bone mineral density in adults with cystic fibrosis and to assess possible clinical predictors of osteoporosis.
Design: Retrospective cohort study.
Setting: Academic cystic fibrosis center.
Patients: 70 adults with late-stage cystic fibrosis who were referred for lung transplantation.
Measurements: Bone mineral density was measured with dual-energy x-ray absorptiometry, patient-reported fracture events were confirmed by radiography, and kyphosis angles were measured by using the Cobb method.
Results: Mean bone mineral densities for the spine, femur, and total body were severely depressed in patients with cystic fibrosis, averaging 2 SDs below those of age-matched normal controls (P < 0.001). Patient interviews showed that 54 fractures had occurred over 1410 patient-years, and chest radiographs showed evidence of 14 additional rib and 62 additional vertebral compression fractures. The database (which covered 1410 patient-years) showed that fracture rates were approximately twofold greater in women with cystic fibrosis aged 16 to 34 years (P = 0.015) and men with cystic fibrosis aged 25 to 45 years (P = 0.04) than in the general population. Vertebral compression and rib fractures were 100- and 10-fold more common than expected, respectively (P < 0.001 for both comparisons). The mean kyphosis angle (±SD) for this group was markedly abnormal (44 ± 14 degrees; 62%
Conclusions: Osteoporosis is universal in adults with late-stage cystic fibrosis, and its complications include increased fracture rates and severe kyphosis.
Author and Article Information
From the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and Duke University Medical Center, Durham, North Carolina.
ARTICLE
Increased Rate of Fractures and Severe Kyphosis: Sequelae of Living into Adulthood with Cystic Fibrosis
40 degrees) and probably contributed to diminished stature (mean height loss, 5.8 cm in men with cystic fibrosis and 5.9 cm in women with cystic fibrosis). Cumulative prednisone dose, body mass index, and age at puberty were the strongest predictors of bone mineral density.
![]()
Acknowledgments: The authors thank Susan Hayden for support and patience; Drs. Thomas Egan, Frank Detterbeck, and Linda Paradowski (lung transplantation physicians) and Kristi Gott, Jean Rea, and Judy McSweeney (lung transplantation coordinators) for managing the cystic fibrosis lung transplant center, which encouraged the referrals that allowed this study to be done; and Mary Bates for manuscript assistance.
Grant Support: By Cystic Fibrosis Foundation grant A936 and the Verne S. Caviness General Center for Clinical Research (NIH RR00046).
Requests for Reprints: Robert Aris, MD, Division of Pulmonary Medicine, CB# 7020, 724 Burnett-Womack Building, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7524.
Current Author Addresses: Drs. Aris and Winders: Division of Pulmonary Medicine, CB# 7020, 724 Burnett-Womack Building, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7524.
This article has been cited by other articles:
![]() |
T. M. Kremer, R. G. Zwerdling, P. H. Michelson, and B. P. O'Sullivan Intensive Care Management of the Patient With Cystic Fibrosis J Intensive Care Med, May 1, 2008; 23(3): 159 - 177. [Abstract] [PDF] |
||||
![]() |
C. Guilbault, Z. Saeed, G. P. Downey, and D. Radzioch Cystic Fibrosis Mouse Models Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Shead, C. S. Haworth, E. Gunn, D. Bilton, M. A. Scott, and J. E. Compston Osteoclastogenesis during Infective Exacerbations in Patients with Cystic Fibrosis Am. J. Respir. Crit. Care Med., August 1, 2006; 174(3): 306 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tschopp, C. Schmid, R. Speich, B. Seifert, E. W. Russi, and A. Boehler Pretransplantation bone disease in patients with primary pulmonary hypertension. Chest, April 1, 2006; 129(4): 1002 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
H M Buntain, P J Schluter, S C Bell, R M Greer, J C H Wong, J Batch, P Lewindon, and C E Wainwright Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis Thorax, February 1, 2006; 61(2): 146 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
M E Dodd and S A Prasad Physiotherapy management of cystic fibrosis Chronic Respiratory Disease, July 1, 2005; 2(3): 139 - 149. [Abstract] [PDF] |
||||
![]() |
N. M. Maalouf and E. Shane Osteoporosis after Solid Organ Transplantation J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2456 - 2465. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Aris, P. A. Merkel, L. K. Bachrach, D. S. Borowitz, M. P. Boyle, S. L. Elkin, T. A. Guise, D. S. Hardin, C. S. Haworth, M. F. Holick, et al. Guide to Bone Health and Disease in Cystic Fibrosis J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1888 - 1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Aris and T. A. Guise Cystic fibrosis and bone disease: are we missing a genetic link? Eur. Respir. J., January 1, 2005; 25(1): 9 - 11. [Full Text] [PDF] |
||||
![]() |
S. J. King, D. J. Topliss, T. Kotsimbos, I. B. Nyulasi, M. Bailey, P. R. Ebeling, and J. W. Wilson Reduced bone density in cystic fibrosis: {Delta}F508 mutation is an independent risk factor Eur. Respir. J., January 1, 2005; 25(1): 54 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
S P Conway, B Oldroyd, A Morton, J G Truscott, and D G Peckham Effect of oral bisphosphonates on bone mineral density and body composition in adult patients with cystic fibrosis: a pilot study Thorax, August 1, 2004; 59(8): 699 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
C S Haworth, P L Selby, A K Webb, L Martin, J S Elborn, L D Sharples, and J E Adams Inflammatory related changes in bone mineral content in adults with cystic fibrosis Thorax, July 1, 2004; 59(7): 613 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Gluck and G. Colice Recognizing and Treating Glucocorticoid-Induced Osteoporosis in Patients With Pulmonary Diseases Chest, May 1, 2004; 125(5): 1859 - 1876. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Gourlay and S. A. Brown Clinical Considerations in Premenopausal Osteoporosis Arch Intern Med, March 22, 2004; 164(6): 603 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
H M Buntain, R M Greer, P J Schluter, J C H Wong, J A Batch, J M Potter, P J Lewindon, E Powell, C E Wainwright, and S C Bell Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study Thorax, February 1, 2004; 59(2): 149 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Aris, G. E. Lester, M. Caminiti, A. D. Blackwood, M. Hensler, R. K. Lark, T. M. Hecker, J. B. Renner, U. Guillen, S. A. Brown, et al. Efficacy of Alendronate in Adults with Cystic Fibrosis with Low Bone Density Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 77 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Ionescu, W. D. Evans, R. J. Pettit, L. S. Nixon, M. D. Stone, and D. J. Shale Hidden Depletion of Fat-Free Mass and Bone Mineral Density in Adults With Cystic Fibrosis Chest, December 1, 2003; 124(6): 2220 - 2228. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Aris, D. A. Ontjes, S. A. Brown, W. Chalermskulrat, I. Neuringer, and G. E. Lester Carboxylated Osteocalcin Levels in Cystic Fibrosis Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1129 - 1129. [Full Text] [PDF] |
||||
![]() |
K. J Schulze, K. O O'Brien, E. L Germain-Lee, D. J Baer, A. Leonard, and B. J Rosenstein Efficiency of calcium absorption is not compromised in clinically stable prepubertal and pubertal girls with cystic fibrosis Am. J. Clinical Nutrition, July 1, 2003; 78(1): 110 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
C S Haworth, P L Selby, A W Horrocks, E B Mawer, J E Adams, and A K Webb A prospective study of change in bone mineral density over one year in adults with cystic fibrosis Thorax, August 1, 2002; 57(8): 719 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. IONESCU, L. S. NIXON, S. LUZIO, V. LEWIS-JENKINS, W. D. EVANS, M. D. STONE, D. R. OWENS, P. A. ROUTLEDGE, and D. J. SHALE Pulmonary Function, Body Composition, and Protein Catabolism in Adults with Cystic Fibrosis Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 495 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Sood, G Hambleton, M Super, W D Fraser, J E Adams, and M Z Mughal Bone status in cystic fibrosis Arch. Dis. Child., June 1, 2001; 84(6): 516 - 520. [Abstract] [Full Text] |
||||
![]() |
R. K Lark, G. E Lester, D. A Ontjes, A. D Blackwood, B. W Hollis, M. M Hensler, and R. M Aris Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients Am. J. Clinical Nutrition, March 1, 2001; 73(3): 602 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Soyka, W. P. Fairfield, and A. Klibanski Hormonal Determinants and Disorders of Peak Bone Mass in Children J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 3951 - 3963. [Full Text] |
||||
![]() |
R. M. ARIS, A. R. STEPHENS, D. A. ONTJES, A. DENENE BLACKWOOD, R. K. LARK, M. B. HENSLER, I. P. NEURINGER, and G. E. LESTER Adverse Alterations in Bone Metabolism Are Associated with Lung Infection in Adults with Cystic Fibrosis Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1674 - 1678. [Abstract] [Full Text] |
||||
![]() |
A. A. IONESCU, L. S. NIXON, W. D. EVANS, M. D. STONE, V. LEWIS-JENKINS, K. CHATHAM, and D. J. SHALE Bone Density, Body Composition, and Inflammatory Status in Cystic Fibrosis Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 789 - 794. [Abstract] [Full Text] |
||||
![]() |
R. M. ARIS, G. E. LESTER, J. B. RENNER, A. WINDERS, A. DENENE BLACKWOOD, R. K. LARK, and D. A. ONTJES Efficacy of Pamidronate for Osteoporosis in Patients with Cystic Fibrosis following Lung Transplantation Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): 941 - 946. [Abstract] [Full Text] |
||||
![]() |
S P Conway, A M Morton, B Oldroyd, J G Truscott, H White, A H Smith, and I Haigh Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors Thorax, September 1, 2000; 55(9): 798 - 804. [Abstract] [Full Text] |
||||
![]() |
C. S. Haworth, A. K. Webb, J. J. Egan, P. L. Selby, P. S. Hasleton, P. W. Bishop, and T. J. Freemont Bone Histomorphometry in Adult Patients With Cystic Fibrosis Chest, August 1, 2000; 118(2): 434 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Davis and C. M. Kercsmar Growth in Children with Chronic Lung Disease N. Engl. J. Med., March 23, 2000; 342(12): 887 - 888. [Full Text] |
||||
![]() |
D. S. DONOVAN Jr., A. PAPADOPOULOS, R. B. STARON, V. ADDESSO, L. SCHULMAN, C. MCGREGOR, F. COSMAN, R. L. LINDSAY, and E. SHANE Bone Mass and Vitamin D Deficiency in Adults with Advanced Cystic Fibrosis Lung Disease Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1892 - 1899. [Abstract] [Full Text] [PDF] |
||||